Results 51 to 60 of about 17,596 (298)

Repeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations

open access: yesAdvances in Radiation Oncology, 2020
Purpose: Lung reirradiation for nonsmall cell lung cancer (NSCLC) is common for either recurrent disease or new primary cancer. Dose volume tolerance of the lung after multiple courses of radiation therapy (RT) is unknown.
Anthony Ricco, MD   +10 more
doaj   +1 more source

The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate Cancer

open access: yesCancers, 2022
Simple Summary Magnetic resonance imaging is commonly used in pre-treatment prostate cancer diagnostics. The assessment includes a five-stage scale classification called Prostate Imaging-Reporting and Data System (PI-RADS), routinely used to describe the
M. Miszczyk   +13 more
semanticscholar   +1 more source

Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy. [PDF]

open access: yes, 2018
Purpose/objectivesFor lung stereotactic body radiation therapy (SBRT), real-time tumor tracking (RTT) allows for less radiation to normal lung compared to the internal target volume (ITV) method of respiratory motion management. To quantify the advantage
Bahig   +32 more
core   +2 more sources

Meningioma Treated With Hypofractionated Stereotactic Radiotherapy Using CyberKnife®: First in the United Arab Emirates

open access: yesCureus, 2022
A 26-year-old premenopausal lady was referred to the Department of Oncology with headaches and easy fatiguability. She had presented with the same complaints a few years ago.
N. Shanbhag   +4 more
semanticscholar   +1 more source

Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at the First Recurrence: A Preliminary Report

open access: yesBrain Sciences, 2022
(1) Background: Hypofractionated stereotactic radiotherapy (HSRT) and anti-vascular endothelial growth factor (VEGF) antibodies have been reported to have a promising survival benefit in recent studies.
Yun Guan   +12 more
doaj   +1 more source

Sodium MRI at 7T for Early Response Evaluation of Intracranial Tumors following Stereotactic Radiotherapy Using the CyberKnife

open access: yesAmerican Journal of Neuroradiology, 2022
Changes in the tissue sodium concentration seen on sodium MR imaging can be used to detect radiobiologic alterations in brain tumors at early time points after CyberKnife radiation therapy. BACKGROUND AND PURPOSE: Conventionally, early treatment response
L. Huang   +14 more
semanticscholar   +1 more source

On the effect of dose delivery temporal domain on the biological effectiveness of central nervous system CyberKnife radiosurgery applications: theoretical assessment using the concept of biologically effective dose

open access: yesPhysics in Medicine and Biology, 2022
Objective: The diversity in technical configuration between clinically available radiosurgery systems, results in accordingly diverse treatment times for the same physical dose prescription, spanning from several min to more than 1 h. This, combined with
A. Moutsatsos   +6 more
semanticscholar   +1 more source

Dosimetric Analysis of Neural and Vascular Structures in Skull Base Tumors Treated with Stereotactic Radiosurgery. [PDF]

open access: yes, 2017
Objective To examine the relationship between the prescribed target dose and the dose to healthy neurovascular structures in patients with vestibular schwannomas treated with stereotactic radiosurgery (SRS).
Bhatt, Jay M   +6 more
core   +1 more source

High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study

open access: yesRadiation Oncology, 2022
Background This retrospective study was performed to evaluate the efficacy and toxicity of high-dose stereotactic body radiotherapy (SBRT) using a CyberKnife® for patients with stage I peripheral non-small cell lung cancer (NSCLC).
Yasuhiro Ryuno   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy